Transforming and improving outcomes for cancer patients using drug enhanced CAR T therapies.
Our Science
Enhancing CAR T cells through targeted protein modulation is the scientific foundation of DeCART. Our goal is to modify underlying CAR T biology ex vivo and in vivo through small molecule pharmacologic control of protein levels. Our ultimate goal is to improve CAR T therapies and outcomes for cancer patients.
Targeted Protein Modulation
CBL-B inhibitors to improve T cell phenotype
Drug enhanced CAR T cell therapies